Ideaya Biosciences has reported positive interim Phase 2 clinical trial data for darovasertib in neoadjuvant uveal melanoma, or UM, as well as a successful Type C meeting with the Food and Drug ...
Global Biosimilar Market is valued at approximately USD 29.4 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 17.8% over the forecast period 2024-2032. Read the ...
The Global Chromatography Reagents Market is estimated at USD 6.13 billion in 2023 and is projected to grow at a CAGR of over 11% during the forecast period from 2024 to 2032, reaching approximately ...